Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI) to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...

Bajaj Healthcare said that it has received approval from the Drug Controller General of India (DCGI) to manufacture both the API and drug formulation of Pimavanserin.

Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...

Parkinson's disease psychosis (PDP) is a common and challenging complication of Parkinson's disease, characterized by hallucinations and delusions. Managing these symptoms is crucial, as they can ...

GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 /IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January ...

Age of PD onset, mean (SD) 60.5(9.9) 61.7(10.9) 61.8(12.2) 0.51 Duration (Y), mean (SD) 10.2(7.0) 7.3(5.3) 7.2(5.3) 0.002 Abbreviations: n, number; Y, years; SD, standard deviation; mH-Y, modified ...

including Parkinson's Disease Psychosis (PDP). One of the most distressing manifestations of PDP is visual hallucinations (VH), where individuals see things that are not present. Recent research ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

With just over 100 days as CEO now under her belt, Catherine Owen Adams is looking to cruise rare disease-focused Acadia ...

The sample size was calculated to be 375 because 60 psychosis events were required within the 2-year period (multiple variable logistic analysis of six kinds of medications). Age of PD onset ...

Nuplazid (pimavanserin) is already FDA-approved to treat psychosis caused by Parkinson's disease, but Acadia's hope to expanding that use to the Alzheimer's population were shot down by a complete ...